Economic issues in coronary heart disease prevention
- 1 December 1996
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 7 (6) , 356-362
- https://doi.org/10.1097/00041433-199612000-00003
Abstract
The effectiveness of cholesterol lowering is well established, but cost-effectiveness is an increasing issue because of financial pressures on healthcare services. New statin studies have prospectively demonstrated that secondary prevention of coronary heart disease is almost always cost-effective, as is primary prevention in individuals at higher risk who have one or more other additional risk factors.Keywords
This publication has 0 references indexed in Scilit: